Description
Erlonat 150mg
The pancreas drips enzymes that help in digestion and secretes hormones required to regulate sugar metabolism. Pancreatic cancer initiates in the pancreatic tissues, but the most predominant type of pancreatic cancer begins in the cell linings of the duct carrying digestive enzymes. Lung Cancer begins at any part of the lungs. There are two major types of lung cancer: small cell lung cancer and non-small cell lung cancer that usually includes causes such as exposure to particular toxins, smoking, and ancestry history. Pancreatic metastases appear in the near end-stage of small cell lung cancer. Though it is rare, the major hazards of these lesions are obstructive jaundice and acute pancreatitis. For treating this pancreatic and lung cancer, Erlotinib 150 mg is used.
The Erlotinib 150 mg is helpful and safe for non-smoker patients to treat advanced Adenocarcinoma.
Erlotinib 150 mg is a specific tyrosine kinase inhibitor specified for Non-Small Cell lung cancer (NSCLC) and Pancreatic cancer medication. Erlotinib contains erlotinib hydrochloride, and it is a film-coated tablet. It is prescribed for the first-line therapy of sufferers with locally progressive or metastatic NSCLC (Non-Small Cell lung cancer) with EGFR (Epidermal Growth Factor Receptor) triggering mutations or for the patients with stable ailment after first-line chemotherapy. The Erlotinib price in India is Rs. 2,300/box and Rs. 8,500/bottle.
Victims with locally developed and metastatic non-small lung cancer can take this drug with a combination of gemcitabine as a first-time therapy but only as per the proper prescription.
We have strong global networks in AFRICA, Europe, United Kingdom, United States, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, Unites Arab Emirates, Thailand, Vietnam, Middle East and South East Countries.
Reviews
There are no reviews yet.